Clinical Trial Update: Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pharmacodynamics, safety/tolerability and efficacy of topical omiganan in patients with Usual Type Vulval Intraepithelial Neoplasia (uV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulval Intraepithelial Neoplasia

Drugs mentioned

• Omiganan topical (omiganan)

Snippet

Sponsor: Maruho Co., Ltd. | Conditions: Usual Type Vulval Intraepithelial Neoplasia (uVIN) | Phase 2 | Status: COMPLETED